Aimed Bio (0009K0) has 0 disclosed insider purchases and 6 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩143.5B ($99.6M) in reported transaction value. The earliest filing StockDrifts holds for Aimed Bio is dated 2025-12-04; the most recent is 2026-03-16. Across these filings the average return since disclosure is +13.28%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-09-11 | BUY | 주식매수선택권 | 안선희 Seonhee Ahn | moving | 15.0K | ₩22,650 | -4.4% | ₩340M ($236K) |
| 2026-03-16 | SELL | Market Sell | 인터베스트 Intervest | - | -67.1K | ₩64,300 | +17.3% | ₩4.3B ($3.0M) |
| 2026-03-13 | SELL | Market Sell | 인터베스트 Intervest | - | -80.0K | ₩69,400 | +23.3% | ₩5.6B ($3.9M) |
| 2026-03-12 | SELL | Market Sell | 인터베스트 Intervest | - | -650.0K | ₩70,300 | +24.3% | ₩45.7B ($31.7M) |
| 2026-03-11 | SELL | Market Sell | 인터베스트 Intervest | - | -500.0K | ₩65,100 | +18.3% | ₩32.5B ($22.6M) |
| 2026-03-10 | SELL | Market Sell | 인터베스트 Intervest | - | -450.0K | ₩64,400 | +17.4% | ₩29.0B ($20.1M) |
| 2026-02-04 | SELL | 시간외매매 | 인터베스트 Intervest | - | -1.0M | ₩55,600 | +4.3% | ₩55.6B ($38.6M) |
| 2026-01-02 | BUY | 주식매수선택권 | 허남구 Heonam-gu | CEO | 65.0K | ₩54,700 | -2.7% | ₩3.6B ($2.5M) |
| 2026-01-02 | BUY | 주식매수선택권 | 민병귀 Min Byeong-gwi | Director of Research Institute | 50.0K | ₩54,700 | -2.7% | ₩2.7B ($1.9M) |
| 2026-01-02 | BUY | 주식매수선택권 | 김태경 Taekyung Kim | COO | 85.0K | ₩54,700 | -2.7% | ₩4.6B ($3.2M) |
| 2026-01-02 | BUY | 주식매수선택권 | 김미현 Mihyeon Kim | moving | 30.0K | ₩54,700 | -2.7% | ₩1.6B ($1.1M) |
| 2026-01-02 | BUY | 주식매수선택권 | 안선희 Seonhee Ahn | moving | 20.0K | ₩54,700 | -2.7% | ₩1.1B ($760K) |
| 2025-12-04 | SELL | Market Sell | 인터베스트 Intervest | - | -600.0K | ₩44,000 | -20.9% | ₩26.4B ($18.3M) |
| 2025-12-04 | BUY | 신규상장 | 남도현 Nam Dohyun | CTO | 22.2M | ₩44,000 | +20.9% | ₩975.2B ($677.3M) |
| 2025-12-04 | BUY | 신규상장 | 인터베스트 Intervest | - | 10.2M | ₩44,000 | +20.9% | ₩448.6B ($311.5M) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse the Korean stocks we cover.